Perceptive Advisors – SYNDAX PHARMACEUTICALS

Perceptive Advisors ownership history of SYNDAX PHARMACEUTICALS
QuarterValueSharesWeighting
Q1 2021$12,074
81.0%
540,000
80.0%
0.08%
5.6%
Q4 2020$6,672300,0000.07%